Index of /wp-content/uploads/2012/03/
Name
Last Modified
Size
Parent Directory
Agomelatine-Valdoxan-summary.pdf
2023-03-09 11:31
84k
Agomelatine-Valdoxan-summary1.pdf
2023-03-09 11:31
84k
All-1024x215.jpg
2023-03-09 11:31
44k
All-150x150.jpg
2023-03-09 11:31
8k
All-300x63.jpg
2023-03-09 11:31
8k
All.jpg
2023-03-09 11:31
844k
Alternative-approaches-to-the-economic-evaluation-of-a-drug-for-patients-with...
2023-03-09 11:31
44k
Alternative-approaches-to-the-economic-evaluation-of-a-drug-for-patients-with...
2023-03-09 11:31
44k
Ambrisentan-Volibris-summary.pdf
2023-03-09 11:31
92k
An-Economic-Evaluation-of-Eculizumab-summary.pdf
2023-03-09 11:31
84k
AW-150x150.jpg
2023-03-09 11:31
8k
AW-240x300.jpg
2023-03-09 11:31
12k
AW.jpg
2023-03-09 11:31
168k
Boceprevir-Victrelis-summary.pdf
2023-03-09 11:31
44k
Cabazitaxel-Summary-for-website.pdf
2023-03-09 11:31
92k
Checklist-for-PE-Submissions-05.2012.pdf
2023-03-09 11:31
100k
Checklist-for-PE-Submissions-05.20121.pdf
2023-03-09 11:31
100k
Checklist-for-PE-Submissions-05.20122.pdf
2023-03-09 11:31
100k
Checklist-for-PE-Submissions-05.20123.pdf
2023-03-09 11:31
100k
Cimzia-Summary-for-website-LT-comments-2.pdf
2023-03-09 11:31
76k
CNiC-1-150x150.jpg
2023-03-09 11:31
8k
CNiC-1-240x300.jpg
2023-03-09 11:31
12k
CNiC-1.jpg
2023-03-09 11:31
188k
CNiC-150x150.jpg
2023-03-09 11:31
8k
CNiC-240x300.jpg
2023-03-09 11:31
12k
CNiC.jpg
2023-03-09 11:31
188k
Cost-effective-prescribing-of-proton-pump-inhibitors-PPIs-int-he-GMS-Scheme-A...
2023-03-09 11:31
28k
Cost-Effectiveness-of-Beta-Blocker-Therapy-for-Patients-with-Chronic-Severe-H...
2023-03-09 11:31
120k
Cost-Effectiveness-of-Beta-Blocker-Therapy-for-Patients-with-Chronic-Severe-H...
2023-03-09 11:31
120k
Cost-Effectiveness-of-Spironolactone-in-Patients-with-Severe-Heart-Failure-At...
2023-03-09 11:31
136k
Cost-of-treating-acute-myocardial-infarction-in-an-Irish-teaching-hospital-At...
2023-03-09 11:31
36k
Cost-of-treating-Heart-Failrue-in-an-Irish-teaching-hospital-Attachment.pdf
2023-03-09 11:31
48k
Cost-of-treating-stroke-in-an-Irish-teaching-hospital-Attachment.pdf
2023-03-09 11:31
48k
Dabigatran-Etexilate-Pradaxa-in-AFsummary.pdf
2023-03-09 11:31
88k
Dabigatran-Etexilate-Pradaxa-VTE-Prevention-summary.pdf
2023-03-09 11:31
84k
Dabigatran-Etexilate-Pradaxa-VTE-Prevention-summary1.pdf
2023-03-09 11:31
84k
Denosumab-XGEVA-summary.pdf
2023-03-09 11:31
40k
Drug-Reimbursement-in-Ireland-Attachment.pdf
2023-03-09 11:31
40k
Fidaxomicin-Dificlir.pdf
2023-03-09 11:31
84k
Fidaxomicin-Dificlir1.pdf
2023-03-09 11:31
84k
FINAL-NCPE-Roflumilast-Evaluation-Summary-011110.pdf
2023-03-09 11:31
80k
Fingolimod-Gilenya-summary.pdf
2023-03-09 11:31
80k
flowchart-270312.ppt
2023-03-09 11:31
268k
Generic-Drug-Utilisation-on-the-General-Medical-Services-Scheme-in-2001-Attac...
2023-03-09 11:31
64k
Glucosamine-Sulfate-Dona-summary.pdf
2023-03-09 11:31
88k
Golimumab-summary-revised-price-June-2010.pdf
2023-03-09 11:31
72k
Inhaled-Insulin-Exubera-summary.pdf
2023-03-09 11:31
148k
Ipilimumab-Yervoy-summary.pdf
2023-03-09 11:31
40k
Lapatinib-Tyverb-summary.pdf
2023-03-09 11:31
44k
Melatonin-Circadin-summary.pdf
2023-03-09 11:31
92k
Microcosting-versus-DRGs-in-the-provision-of-cost-estimates-for-use-in-pharma...
2023-03-09 11:31
132k
Natalizumab-Tysabri-summary.pdf
2023-03-09 11:31
96k
NCPE-Process-Flochart-150x150.png
2023-03-09 11:31
16k
NCPE-Process-Flochart-169x300.png
2023-03-09 11:31
36k
NCPE-Process-Flochart-577x1024.png
2023-03-09 11:31
348k
NCPE-Process-Flochart.png
2023-03-09 11:31
180k
news_doc_116.pdf
2023-03-09 11:31
80k
Nilotinib-Tasigna-summary.pdf
2023-03-09 11:31
80k
Pneumococcal-Conjugate-Vaccine-summary.pdf
2023-03-09 11:31
40k
prasugrel-summary.pdf
2023-03-09 11:31
84k
Recommendations-on-the-reporting-format-and-layout-of-pharmacoeconomic-submis...
2023-03-09 11:31
140k
Rimonabant-Acomplia-summary.pdf
2023-03-09 11:31
96k
Rivaroxaban-for-DVT-web-summary.pdf
2023-03-09 11:31
40k
Rivaroxaban-Xarelto-summary.pdf
2023-03-09 11:31
84k
Rivaroxaban-Xarelto-summary1.pdf
2023-03-09 11:31
84k
Rotavirus-Vaccine-summary.pdf
2023-03-09 11:31
104k
Sapropterin-Kuvan-summary.pdf
2023-03-09 11:31
144k
SSb2-150x150.jpg
2023-03-09 11:31
8k
SSb2-258x300.jpg
2023-03-09 11:31
16k
SSb2-883x1024.jpg
2023-03-09 11:31
156k
SSb2.jpg
2023-03-09 11:31
1560k
Sublingual-Immotherapy-Grazax-summary.pdf
2023-03-09 11:31
84k
Suboxone-summary.pdf
2023-03-09 11:31
88k
Summary-for-Thrombocytopenic-purpura.pdf
2023-03-09 11:31
88k
Summary-Ozurdex-2.pdf
2023-03-09 11:31
84k
Summary-Ozurdex-21.pdf
2023-03-09 11:31
84k
Summary-Ozurdex-22-1.pdf
2023-03-09 11:31
84k
Summary-Ozurdex-22.pdf
2023-03-09 11:31
84k
Summary-Ozurdex-website.pdf
2023-03-09 11:31
84k
Summary-Ozurdex-website1.pdf
2023-03-09 11:31
84k
Summary-Ozurdex-website2.pdf
2023-03-09 11:31
88k
Summary.pdf
2023-03-09 11:31
80k
Summary1.pdf
2023-03-09 11:31
76k
Summary2.pdf
2023-03-09 11:31
112k
Sunitinib-Sutent-summary.pdf
2023-03-09 11:31
92k
Telaprevir-Incivo-summary.pdf
2023-03-09 11:31
44k
The-Irish-National-Centre-for-Pharmacoeconomics-Its-Rationale-and-Role-Attach...
2023-03-09 11:31
48k
The-potential-for-drug-interactions-with-statin-therapy-in-Ireland-Attachment...
2023-03-09 11:31
76k
Ticagrelor-Brilique-summary.pdf
2023-03-09 11:31
40k
Universal-Infant-Hepatitis-B-Vaccine-Programme-summary.pdf
2023-03-09 11:31
16k
Ustekinumab-Stelara-summary.pdf
2023-03-09 11:31
16k
Vernakalant-Brinavess-summary.pdf
2023-03-09 11:31
76k
Proudly Served by LiteSpeed Web Server at www.ncpe.ie Port 443